It was a busy summer for Chinese pharmaceutical companies and investors who went global shopping, eying mega acquisition deals since China announced plans to accept overseas clinical trial data and global multicenter studies as part of its policies.

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

Noteworthy news from medtech start-ups. This month we profile Silere Medical, which is developing neurostimulation technology to suppress tinnitus, OrthoData, which makes an implantable diagnostic device to monitor spinal fusion, and ProTip, which is developing porous titanium devices for ear, nose and throat applications.

Cyberkinetics is developing an implantable brain-machine interface initially aimed at helping paralyzed patients communicate through a computer that they control mentally. Ultimately, the firm views its BMI technology as a platform applicable to treating a wide range of neurological disorders.